Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Dec;83(12):1681–1687. doi: 10.1054/bjoc.2000.1484

Clinicopathologic significance of sialyl Le xexpression in advanced gastric carcinoma

N Futamura 1, S Nakamura 2, M Tatematsu 3, Y Yamamura 4, R Kannagi 5, H Hirose 1
PMCID: PMC2363447  PMID: 11104566

Abstract

Sialyl Lewis xantigen (SLX) is a carbohydrate antigen that serves as a ligand for selectin, an adhesion molecule expressed on vascular endothelial cells. The expression of SLX in 245 patients with advanced gastric carcinoma was examined immunohistochemically, and its clinicopathologic significance was analysed. We classified the patients with advanced gastric carcinoma into 91 with differentiated type and 154 with undifferentiated type. SLX expressed in 135 of 245 patients (55%), comprising 68 (75%) patients with differentiated carcinoma and 67 (44%) with undifferentiated carcinoma. The positive rate for SLX expression was significantly higher among patients with differentiated carcinoma than among those in undifferentiated carcinoma (P < 0.0001). With differentiated carcinoma, the incidence of lymph node metastasis, advanced tumour stage (stage III and IV) and liver recurrence was significantly higher in SLX-positive patients than in SLX-negative ones (P  < .0001, P = 0.0065 and P = 0.028, respectively). Moreover, the prognoses were better in patients with SLX-negative tumours than in those with SLX-positive tumours (P = 0.019). With undifferentiated carcinoma, there were no significant correlations between SLX expression and any clinicopathological features or prognoses. The clinicopathologic significance of SLX expression in gastric carcinoma patients depends on histologic type. SLX expression may be of great relevance in predicting liver metastases in patients with differentiated carcinoma. © 2000 Cancer Research Campaign http://www.bjcancer.com

Keywords: gastric carcinoma, sialyl Le x, SNH-3, immunohistochemistry

Full Text

The Full Text of this article is available as a PDF (339.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akiyama S., Amo H., Watanabe T., Matsuyama M., Sakamoto J., Imaizumi M., Ichihashi H., Kondo T., Takagi H. Characteristics of three human gastric cancer cell lines, NU-GC-2, NU-GC-3 and NU-GC-4. Jpn J Surg. 1988 Jul;18(4):438–446. doi: 10.1007/BF02471470. [DOI] [PubMed] [Google Scholar]
  2. Amado M., Carneiro F., Seixas M., Clausen H., Sobrinho-Simões M. Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology. 1998 Mar;114(3):462–470. doi: 10.1016/s0016-5085(98)70529-3. [DOI] [PubMed] [Google Scholar]
  3. Bresalier R. S., Ho S. B., Schoeppner H. L., Kim Y. S., Sleisenger M. H., Brodt P., Byrd J. C. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology. 1996 May;110(5):1354–1367. doi: 10.1053/gast.1996.v110.pm8613039. [DOI] [PubMed] [Google Scholar]
  4. Cannistra S. A., Kansas G. S., Niloff J., DeFranzo B., Kim Y., Ottensmeier C. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res. 1993 Aug 15;53(16):3830–3838. [PubMed] [Google Scholar]
  5. Dohi T., Abe K., Ohshiba S. Immunohistochemical study of carbohydrate antigen expression in gastric carcinoma. Gastroenterol Jpn. 1989 Jun;24(3):239–245. doi: 10.1007/BF02774320. [DOI] [PubMed] [Google Scholar]
  6. Duarte I., Llanos O. Patterns of metastases in intestinal and diffuse types of carcinoma of the stomach. Hum Pathol. 1981 Mar;12(3):237–242. doi: 10.1016/s0046-8177(81)80124-4. [DOI] [PubMed] [Google Scholar]
  7. Esaki Y., Hirayama R., Hirokawa K. A comparison of patterns of metastasis in gastric cancer by histologic type and age. Cancer. 1990 May 1;65(9):2086–2090. doi: 10.1002/1097-0142(19900501)65:9<2086::aid-cncr2820650933>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  8. Ikeda Y., Mori M., Kajiyama K., Haraguchi Y., Sasaki O., Sugimachi K. Immunohistochemical expression of sialyl Tn, sialyl Lewis a, sialyl Lewis a-b-, and sialyl Lewis x in primary tumor and metastatic lymph nodes in human gastric cancer. J Surg Oncol. 1996 Jul;62(3):171–176. doi: 10.1002/(SICI)1096-9098(199607)62:3<171::AID-JSO5>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  9. Izumi Y., Taniuchi Y., Tsuji T., Smith C. W., Nakamori S., Fidler I. J., Irimura T. Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells. Exp Cell Res. 1995 Jan;216(1):215–221. doi: 10.1006/excr.1995.1027. [DOI] [PubMed] [Google Scholar]
  10. Jørgensen T., Berner A., Kaalhus O., Tveter K. J., Danielsen H. E., Bryne M. Up-regulation of the oligosaccharide sialyl LewisX: a new prognostic parameter in metastatic prostate cancer. Cancer Res. 1995 May 1;55(9):1817–1819. [PubMed] [Google Scholar]
  11. LAUREN P. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965;64:31–49. doi: 10.1111/apm.1965.64.1.31. [DOI] [PubMed] [Google Scholar]
  12. Lowe J. B., Stoolman L. M., Nair R. P., Larsen R. D., Berhend T. L., Marks R. M. ELAM-1--dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA. Cell. 1990 Nov 2;63(3):475–484. doi: 10.1016/0092-8674(90)90444-j. [DOI] [PubMed] [Google Scholar]
  13. Ming S. C. Gastric carcinoma. A pathobiological classification. Cancer. 1977 Jun;39(6):2475–2485. doi: 10.1002/1097-0142(197706)39:6<2475::aid-cncr2820390626>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  14. Mori M., Sakaguchi H., Akazawa K., Tsuneyoshi M., Sueishi K., Sugimachi K. Correlation between metastatic site, histological type, and serum tumor markers of gastric carcinoma. Hum Pathol. 1995 May;26(5):504–508. doi: 10.1016/0046-8177(95)90246-5. [DOI] [PubMed] [Google Scholar]
  15. NAGAYO T., KOMAGOE T. Histological studies of gastric mucosal cancer with special reference to relationship of histological pictures between the mucosal cancer and the cancer-bearing gastric mucosa. Gan. 1961 Jun;52:109–119. [PubMed] [Google Scholar]
  16. Nakagoe T., Fukushima K., Hirota M., Kusano H., Ayabe H., Tomita M., Kamihira S. Immunohistochemical expression of sialyl Lex antigen in relation to survival of patients with colorectal carcinoma. Cancer. 1993 Oct 15;72(8):2323–2330. doi: 10.1002/1097-0142(19931015)72:8<2323::aid-cncr2820720807>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  17. Nakamori S., Furukawa H., Hiratsuka M., Iwanaga T., Imaoka S., Ishikawa O., Kabuto T., Sasaki Y., Kameyama M., Ishiguro S. Expression of carbohydrate antigen sialyl Le(a): a new functional prognostic factor in gastric cancer. J Clin Oncol. 1997 Feb;15(2):816–825. doi: 10.1200/JCO.1997.15.2.816. [DOI] [PubMed] [Google Scholar]
  18. Nakamori S., Kameyama M., Imaoka S., Furukawa H., Ishikawa O., Sasaki Y., Kabuto T., Iwanaga T., Matsushita Y., Irimura T. Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res. 1993 Aug 1;53(15):3632–3637. [PubMed] [Google Scholar]
  19. Narita T., Funahashi H., Satoh Y., Watanabe T., Sakamoto J., Takagi H. Association of expression of blood group-related carbohydrate antigens with prognosis in breast cancer. Cancer. 1993 May 15;71(10):3044–3053. doi: 10.1002/1097-0142(19930515)71:10<3044::aid-cncr2820711026>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  20. Phillips M. L., Nudelman E., Gaeta F. C., Perez M., Singhal A. K., Hakomori S., Paulson J. C. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science. 1990 Nov 23;250(4984):1130–1132. doi: 10.1126/science.1701274. [DOI] [PubMed] [Google Scholar]
  21. Rhomberg W., Gruber U. Liver metastasis in cancer of the stomach and its dependence on the histology of the primary tumor: an autopsy study on 102 cases. Clin Exp Metastasis. 1989 Nov-Dec;7(6):585–590. doi: 10.1007/BF01753669. [DOI] [PubMed] [Google Scholar]
  22. Saitoh O., Wang W. C., Lotan R., Fukuda M. Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem. 1992 Mar 15;267(8):5700–5711. [PubMed] [Google Scholar]
  23. Sawada R., Tsuboi S., Fukuda M. Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem. 1994 Jan 14;269(2):1425–1431. [PubMed] [Google Scholar]
  24. Takada A., Ohmori K., Takahashi N., Tsuyuoka K., Yago A., Zenita K., Hasegawa A., Kannagi R. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem Biophys Res Commun. 1991 Sep 16;179(2):713–719. doi: 10.1016/0006-291x(91)91875-d. [DOI] [PubMed] [Google Scholar]
  25. Takada A., Ohmori K., Yoneda T., Tsuyuoka K., Hasegawa A., Kiso M., Kannagi R. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 1993 Jan 15;53(2):354–361. [PubMed] [Google Scholar]
  26. Ura H., Denno R., Hirata K., Yamaguchi K., Yasoshima T., Shishido T. Close correlation between increased sialyl-Lewisx expression and metastasis in human gastric carcinoma. World J Surg. 1997 Sep;21(7):773–776. doi: 10.1007/s002689900304. [DOI] [PubMed] [Google Scholar]
  27. Walz G., Aruffo A., Kolanus W., Bevilacqua M., Seed B. Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science. 1990 Nov 23;250(4984):1132–1135. doi: 10.1126/science.1701275. [DOI] [PubMed] [Google Scholar]
  28. Wronkowski Z., Stemmermann G., Rellahan W. Stomach carcinoma among Hawaiians and Caucasians in Hawaii. Cancer. 1977 May;39(5):2310–2316. doi: 10.1002/1097-0142(197705)39:5<2310::aid-cncr2820390553>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES